Balyasny Asset Management L.P. Has $261,000 Position in Enhabit, Inc. (NYSE:EHAB)

Balyasny Asset Management L.P. lowered its holdings in Enhabit, Inc. (NYSE:EHAB - Free Report) by 61.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 33,454 shares of the company's stock after selling 52,475 shares during the quarter. Balyasny Asset Management L.P. owned 0.07% of Enhabit worth $261,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its holdings in shares of Enhabit by 37.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company's stock worth $2,411,000 after purchasing an additional 83,707 shares in the last quarter. Empowered Funds LLC grew its holdings in shares of Enhabit by 5.0% during the 4th quarter. Empowered Funds LLC now owns 175,824 shares of the company's stock worth $1,373,000 after purchasing an additional 8,448 shares in the last quarter. Stoneridge Investment Partners LLC grew its holdings in shares of Enhabit by 22.6% during the 4th quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company's stock worth $98,000 after purchasing an additional 2,308 shares in the last quarter. Rhumbline Advisers grew its holdings in shares of Enhabit by 2.8% during the 4th quarter. Rhumbline Advisers now owns 80,760 shares of the company's stock worth $631,000 after purchasing an additional 2,211 shares in the last quarter. Finally, Paradice Investment Management LLC grew its holdings in shares of Enhabit by 12.8% during the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock worth $13,903,000 after purchasing an additional 201,997 shares in the last quarter.

Enhabit Price Performance

Enhabit stock traded down $0.04 during mid-day trading on Friday, hitting $10.22. 209,368 shares of the company were exchanged, compared to its average volume of 455,986. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The business has a fifty day moving average of $8.70 and a 200 day moving average of $8.30. Enhabit, Inc. has a 1-year low of $6.85 and a 1-year high of $10.79. The company has a market capitalization of $517.31 million, a PE ratio of -4.40 and a beta of 1.61.

Enhabit (NYSE:EHAB - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.03. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The firm had revenue of $259.90 million during the quarter, compared to analyst estimates of $266.11 million. As a group, sell-side analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Analyst Ratings Changes

Separately, Jefferies Financial Group reissued a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.